OX40L blockade protects against inflammation-driven fibrosis
OX40L blockade protects against inflammation-driven fibrosis
About this item
Full title
Author / Creator
Elhai, Muriel , Avouac, Jérôme , Hoffmann-Vold, Anna Maria , Ruzehaji, Nadira , Amiar, Olivia , Ruiz, Barbara , Brahiti, Hassina , Ponsoye, Matthieu , Fréchet, Maxime , Burgevin, Anne , Pezet, Sonia , Sadoine, Jérémy , Guilbert, Thomas , Nicco, Carole , Akiba, Hisaya , Heissmeyer, Vigo , Subramaniam, Arun , Resnick, Robert , Molberg, Øyvind , Kahan, André , Chiocchia, Gilles and Allanore, Yannick
Publisher
United States: National Academy of Sciences
Journal title
Language
English
Formats
Publication information
Publisher
United States: National Academy of Sciences
Subjects
More information
Scope and Contents
Contents
Treatment for fibrosis represents a critical unmet need, because fibrosis is the leading cause of death in industrialized countries, and there is no effective therapy to counteract the fibrotic process. The development of fibrosis relates to the interplay between vessel injury, immune cell activation, and fibroblast stimulation, which can occur in...
Alternative Titles
Full title
OX40L blockade protects against inflammation-driven fibrosis
Authors, Artists and Contributors
Author / Creator
Avouac, Jérôme
Hoffmann-Vold, Anna Maria
Ruzehaji, Nadira
Amiar, Olivia
Ruiz, Barbara
Brahiti, Hassina
Ponsoye, Matthieu
Fréchet, Maxime
Burgevin, Anne
Pezet, Sonia
Sadoine, Jérémy
Guilbert, Thomas
Nicco, Carole
Akiba, Hisaya
Heissmeyer, Vigo
Subramaniam, Arun
Resnick, Robert
Molberg, Øyvind
Kahan, André
Chiocchia, Gilles
Allanore, Yannick
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4941508
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4941508
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
DOI
10.1073/pnas.1523512113
